Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat

Neuroscience

Volumn 99, Issue 2, 2000, Pages 289-295

  Benazzouz, A ^a   Gao, D M ^b   Ni, Z G ^a   Piallat, B ^a   Bouali Benazzouz, R ^a   Benabid, A L ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Basal ganglia; Electrical stimulation; Electrophysiology; Globus pallidus; Parkinson's disease

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; ELECTROSTIMULATION; GLOBUS PALLIDUS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; THALAMUS VENTRAL NUCLEUS;

ADRENERGIC AGENTS; ANIMALS; ELECTRIC STIMULATION; GLOBUS PALLIDUS; MALE; OXIDOPAMINE; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; VENTRAL THALAMIC NUCLEI;

EID: 0034638263     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00199-8     Document Type: Article

References (51)

1. Albin R., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
2. Alexander G.E., Crutcher M.O., DeLong M.R. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Prog. Brain Res. 85:1990;119-146.
3. Aziz T.Z., Peggs D., Sambrook M.A., Crossman A.R. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism in the primate. Mov. Disord. 6:1991;288-292.
4. Baunez C., Nieoullon A., Amalric M. In a rat model of Parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit. J. Neurosci. 15:1995;6531-6541.
5. Baunez C., Robbins T.W. Bilateral lesions of the subthalamic nucleus induce multiple deficits in an attentional task in rats. Eur. J. Neurosci. 9:1997;2086-2099.
6. Benabid A.L., Pollak P., Gervason C., Hoffmann D., Gao D.M., Hommel M., Perret J., De Rougemont J. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 337:1991;403-406.
7. Benabid A.L., Pollak P., Louveau A., Henry S., De Rougemont J. Combined (thalamotomy and stimulation) stereotaxic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl. Neurophysiol. 50:1987;344-346.
8. Benazzouz A., Boraud T., Féger J., Burbaud P., Bioulac B., Gross C. Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment. Mov. Disord. 11:1996;627-632.
9. Benazzouz A., Gross C., Féger J., Boraud T., Bioulac B. Reversal of rigidity and improvement in motor performance by subthalamic HFS in MPTP-treated monkeys. Eur. J. Neurosci. 5:1993;382-389.
10. Benazzouz A., Hallett M. Mechanism of action of deep brain stimulation. Neurology, Suppl. 2000;. (in press).
11. Benazzouz A., Piallat B., Pollak P., Benabid A.L. Responses of substantia nigra pars reticulata and globus pallidus complex to HFS of the subthalamic nucleus in rats: electrophysiological data. Neurosci. Lett. 189:1995;77-80.
12. Bergman H., Wichmann T., Delong M.R. Reversal of experimental Parkinsonism by lesions of the subthalamic nucleus. Science. 249:1990;1346-1348.
13. Bergman H., Wichmann T., Karmon B., DeLong M.R. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of Parkinsonism. J. Neurophysiol. 72:1994;507-520.
14. Boraud T., Bezard E., Bioulac B., Gross C. High frequency stimulation of the internal globus pallidus (GPi) simultaneously improves parkinsonian symptoms and reduces the firing frequency of GPi neurons in the MPTP-treated monkey. Neurosci. Lett. 215:1995;17-20.
15. Burbaud P., Gross C., Benazzouz A., Coussemacq M., Bioulac B. Reduction of apomorphine-induced rotational behaviour by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons. Expl Brain Res. 105:1995;48-58.
16. Capparos-Lefebvre D., Blond S., Feltin M.P., Pollak P., Benabid A.L. Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex. J. Neurol. Neurosurg. Psychiat. 67:1999;308-314.
17. Crossman A.R. Neural mechanisms in disorders of movement. Comp. Biochem. Physiol. 93A:1989;141-149.
18. Filion F., Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced Parkinsonism. Brain Res. 547:1991;142-151.
19. Gao D., Benazzouz A., Bressand K., Piallat B., Benabid A.L. Roles of GABA, glutamate, acetylcholine and STN stimulation on thalamic VM in rats. NeuroReport. 8:1997;2601-2605.
20. Gao D.M., Benazzouz A., Piallat B., Bressand K., Ilinsky I.A., Kultas-Ilinsky K., Benabid A.L. High-frequency stimulation of the subthalamic nucleus suppresses experimental resting tremor in the monkey. Neuroscience. 88:1999;201-212.
21. Gill S.S., Heywood P. Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease. Lancet. 350:1997;1224.
22. Gross C., Rougier A., Guehl D., Boraud T., Julien J., Bioulac B. High frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of severe cases. J. Neurosurg. 87:1997;491-498.
23. Hamada I., Delong M.R. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. J. Neurophysiol. 68:1992;1859-1866.
24. Hammond C., Shibazaki T., Rouzaire-Dubois B. Branched output neurons of the rat subthalamic nucleus: electrophysiological study of the synaptic effects on identified cells in the two main target nuclei, the entopeduncular nucleus and the substantia nigra. Neuroscience. 9:1983;511-520.
25. Hassani O.K., Mouroux M., Féger J. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience. 72:1996;105-115.
26. Hollerman J.R., Grace A.A. Subthalamic nucleus cell firing in the 6-OHDA-treated rat: basal activity and response to haloperidol. Brain Res. 590:1992;291-299.
27. Hudson J.L., Vanhorne C.G., Stromberg I., Brock S., Clayton J., Masserano J., Hoffer B.J., Gerhardt G.A. Correlation of apomorphine-induced and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res. 626:1993;167-174.
28. Jenkins I.H., Fernandez W., Playford E.D., Lees A.J., Frackowiak R.S., Passingham R.E., Brooks D.J. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann. Neurol. 32:1992;749-757.
29. Krack P., Benazzouz A., Pollak P., Limousin P., Piallat B., Hoffmann D., Xie J., Benabid A.L. Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov. Disord. 13:1998;907-914.
30. Krack P., Pollak P., Limousin P., Hoffmann D., Benazzouz A., Benabid A.L. Inhibition of levodopa - effects by internal pallidal stimulation. Mov. Disord. 13:1998;648-652.
31. Kreiss D.S., Mastropietro C.W., Rawji S.S., Walters J.R. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J. Neurosci. 17:1997;6807-6819.
32. Laitinen L.V., Bergenheim A.T., Hariz M.I. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J. Neurosurg. 76:1992;53-61.
33. Limousin P., Greene J., Pollak P., Rothwell J., Benabid A.L., Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann. Neurol. 42:1997;283-291.
34. Limousin P., Krack P., Pollak P., Benazzouz A., Ardouin C., Hoffmann D., Benabid A.L. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. New Engl. J. Med. 339:1998;1105-1111.
35. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Le Bas J.F., Broussolle E., Perret J.E., Benabid A.L. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 345:1995;91-95.
36. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Broussolle E., Perret J.E., Benabid A.L. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov. Disord. 10:1995;672-674.
37. Limousin P., Pollak P., Hoffmann D., Benazzouz A., Perret J.E., Benabid A.L. Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov. Disord. 11:1996;231-235.
38. Lozano A.M., Lang A.E., Galvez-Jimenez N., Miyasaki J., Duff J., Hutchinson W.D., Dostrovsky J.O. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet. 346:1995;1383-1387.
39. Miller W. C. and De Long M. R. (1987) Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of Parkinsonism. In The Basal Ganglia II (eds Carpenter M. B. and Jayaraman A.), Vol. 32. Plenum, New York.
40. Murer M.G., Riquelme L.A., Tseng K.Y., Pazo J.H. Substantia nigra pars reticulata single unit activity in normal and 6-OHDA-lesioned rats: effects of intrastriatal apomorphine and subthalamic lesions. Synapse. 27:1997;278-293.
41. Narabayashi H. Stereotaxic VIM thalamotomy for treatment of tremor. Eur. Neurol. 29:(Suppl. 1):1989;29-32.
42. Ohye C., Narabayashi H. Physiological study of the presumed ventralis intermedius neurons in the human thalamus. J. Neurosurg. 50:1979;290-297.
43. Page R.D., Sambrook M.A., Crossman A.R. Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey. Neuroscience. 55:1993;147-165.
44. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1996;Academic, Sydney.
45. Perkins M.N., Stone T.W. Subthalamic projections to the globus pallidus: an electrophysiological study in the rat. Expl Neurol. 68:1980;500-511.
46. Piallat B., Benazzouz A., Benabid A.L. Subthalamic nucleus lesion in rat prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioral and immunohistochemical studies. Eur. J. Neurosci. 8:1996;1408-1414.
47. Robledo P., Féger J. Excitatory influence of the rat subthalamic nucleus to substantia nigra pars reticulata and pallidal complex: electro-physiological data. Brain Res. 518:1990;47-54.
48. Shink E., Bevan M.D., Bolam J.P., Smith Y. The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience. 73:1996;335-357.
49. Smith Y., Parent A. Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain. 453:1988;353-356.
50. Tasker R.R., Siqueira J., Hawrylyshyn P., Organ L.W. What happened to VIM thalamotomy for Parkinson's disease? Appl. Neurophysiol. 46:1983;68-83.
51. Wichmann T., Bergman H., DeLong M.R. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of Parkinsonism. J. Neurophysiol. 72:1994;521-530.